about
Melatonin regulates somatotrope and lactotrope function through common and distinct signaling pathways in cultured primary pituitary cells from female primatesTruncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomasMolecular Characterization of Growth Hormone-producing Tumors in the GC Rat Model of AcromegalyIn1-ghrelin splicing variant is overexpressed in pituitary adenomas and increases their aggressive features.Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors.BIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomas.The truncated somatostatin receptor sst5TMD4 stimulates the angiogenic process and is associated to lymphatic metastasis and disease-free survival in breast cancer patients.Obestatin plays an opposite role in the regulation of pituitary somatotrope and corticotrope function in female primates and male/female mice.Ghrelin gene products, receptors, and GOAT enzyme: biological and pathophysiological insight.Ghrelin O-acyltransferase (GOAT) enzyme is overexpressed in prostate cancer, and its levels are associated with patient's metabolic status: Potential value as a non-invasive biomarker.The Molecular Registry of Pituitary Adenomas (REMAH): A bet of Spanish Endocrinology for the future of individualized medicine and translational research.The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells.Somatotropinomas, but not nonfunctioning pituitary adenomas, maintain a functional apoptotic RET/Pit1/ARF/p53 pathway that is blocked by excess GDNF.Cortistatin: A new link between the growth hormone/prolactin axis, stress, and metabolism.The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressivenessOctreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitro.The oncogenic role of the spliced somatostatin receptor sst5TMD4 variant in prostate cancer.Desmopressin test in the diagnosis and follow-up of cyclical Cushing's disease.Association between radiological parameters and clinical and molecular characteristics in human somatotropinomas.E-cadherin expression is associated with somatostatin analogue response in acromegalyDietary fat alters the expression of cortistatin and ghrelin systems in the PBMCs of elderly subjects: putative implications in the postprandial inflammatory responseOncogenic Role of Secreted Engrailed Homeobox 2 (EN2) in Prostate CancerA Somatostatin Receptor Subtype-3 (SST3) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary TumorsEarly restoration of immune and vascular phenotypes in systemic lupus erythematosus and rheumatoid arthritis patients after B cell depletionBiguanides exert antitumoral actions in pituitary tumor cells through AMPK-dependent and -independent mechanisms
P50
Q35088819-84389594-FA0E-4FB8-B02C-B459147EE6F5Q35228970-276ECBB4-5B6E-4107-ABD4-393C18AB9B1FQ36262428-EE31AF19-C9F7-441F-8184-3A6866823C55Q36291593-1536F87A-9F28-4D1B-8AE1-2E9351085A11Q36916282-13E181AE-FA73-498D-8FED-D691E941E0C9Q37633385-9B32B3AD-519D-40B0-A7DE-5F933A1A6B0BQ37644995-3357F8F3-C94C-4D5B-99F9-CB56C113856DQ37648095-670E2C69-EC7C-43D2-9169-216601CB2D17Q38160209-D7CC6748-312E-4DE8-9DED-46C2196DFE79Q38735971-EB4178F5-A3EB-41EC-9B0F-9025923F523AQ38879404-065547DD-7031-43CF-8D0A-7B38C64B05D7Q38889681-76A8A3E8-6033-4459-8AC0-F20793F3ED66Q38964671-F7C08D29-1504-43C6-AF6C-0C016AE42A45Q39117850-67C984ED-14C4-417A-874C-B1116DBEA527Q41558039-8B564E28-AFD0-49EB-9E32-214CD470D2D9Q48535530-CEEE7D1F-68A5-4D8C-91C7-F5059DAF4442Q50202707-9C6DA778-E191-4B42-BCE1-CBEB0EF48FDFQ53084488-23463326-FC0B-4F2F-92F9-5834757720ECQ55074584-9D212FDB-0AA2-43FF-9B8A-CA48A9824A27Q64040065-096E1F67-FCA9-4BE2-A509-2E8A3E32938FQ88218415-091D7FAA-248C-4DFE-86E6-A9B1981A6104Q89993176-2196756D-8F43-4E97-8A17-D6AC78F340A5Q90780169-A1532578-CA5F-4A21-9560-18E6DB08D0C9Q92198626-AAD1A0F0-1297-4190-8946-F2342B2793EDQ92297114-487EABF1-DD64-4190-9ACA-0862C17B9270
P50
description
researcher ORCID ID = 0000-0003-4649-0095
@en
wetenschapper
@nl
name
Alejandro Ibáñez-Costa
@ast
Alejandro Ibáñez-Costa
@en
Alejandro Ibáñez-Costa
@es
Alejandro Ibáñez-Costa
@nl
type
label
Alejandro Ibáñez-Costa
@ast
Alejandro Ibáñez-Costa
@en
Alejandro Ibáñez-Costa
@es
Alejandro Ibáñez-Costa
@nl
prefLabel
Alejandro Ibáñez-Costa
@ast
Alejandro Ibáñez-Costa
@en
Alejandro Ibáñez-Costa
@es
Alejandro Ibáñez-Costa
@nl
P106
P1153
55876579100
P21
P31
P496
0000-0003-4649-0095